Maxhealth Medical Group China (herein after called Maxhealth) (NEEQ: 836163) is a leading platform for R&D (research and development), production and commercialization of medical technology in China. Based on the unsatisfied real clinical needs, Maxhealth integrates the cutting-edge clinical science, continuously promotes technological progress, improves diagnosis and treatment, and helps patients through transnational innovative R&D.
We have cooperated with a number of global medical innovation institutions and top 500 pharmaceutical companies in R&D, production, market access, academy and product marketing in the Chinese market, and successfully established a link between Chinese and foreign medical technology R&D.
Maxhealth was founded in Wuxi in 2009, with. It has subsidiaries andor offices in Shanghai, Beijing, Hong Kong, London, Tokyo, Auckland and other places. The product portfolio will continue to expand with a focus on the areas of Gastroenterology, Neuro-rehabilitation and Women Health.The company pays special attention to digestion, women's health, nerve rehabilitation and other fields.
